argenx is listed monoclonal antibody company advancing clinical pipeline to treat patients with cancer and severe autoimmune diseases
NightBalance developed and sells the Lunoa, a medical device to provide effective and comfortable treatment for positional sleep apnea. Company was sold to Philips in 2018.
Okapi Sciences developed antiviral drugs for livestock as well as pets. Was acquired by Aratana in 2014.
Nutrileads focuses on the identification and development of food ingredients with a clinically proven positive impact on human health
Indigo Diabetes NV
Leuven-based Indigo develops the next generation needle-free glucose sensors for diabetics.
MILabs develops and sells high-end preclinical maging devices for R&D institutions, and develops a next-gen clinical SPECT scanner with unprecedented performance.
Salvia develops a minimally invasive bioelectronics solution for people suffering from chronic neurological disease.
Develops nanoparticle based drugs to enable more efficacious and safer drugs by improved disposition characteristics.
Atro Medical develops an anatomically shaped polymer based meniscus implant, the Trammpolin, with the aim of restoring the protective function of the meniscus by acting as a joint spacer.
Encare Biotech develops an antibody-based drug to prevent chronic heart failure after a heart attack.
Bioceros provides preclinical antibody services and is also developing a portfolio of biosimilar antibody based products
Develops a single hand operated surgical suturing device for improved speed and accuracy while freeing up one hand of the surgeon.